Ask AI
ES SCLC 1L Therapy

CE / CME

Enhancing Outcomes in Extensive-Stage Small-Cell Lung Cancer With Recent Therapeutic Advancements for First-line Therapy

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

ABIM MOC: maximum of 0.25 Medical Knowledge MOC point

Pharmacists: 0.25 contact hour (0.025 CEUs)

Nurse Practitioners/Nurses: 0.25 Nursing contact hour

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Released: November 10, 2025

Expiration: May 09, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A 70-year-old man (ECOG PS 1) with a 50 pack-year smoking history presents with weight loss and dyspnea. Imaging reveals a 7-cm right lower lobe lung mass with mediastinal lymphadenopathy and multiple liver metastases. Brain MRI is negative. Lymph node biopsy confirms extensive-stage (ES) small-cell lung cancer (SCLC), positive for synaptophysin, with Ki-67 >80%.

Which of the following treatment plans would you recommend for this patient?